BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30154546)

  • 1. Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma.
    Tomko LA; Hill RC; Barrett A; Szulczewski JM; Conklin MW; Eliceiri KW; Keely PJ; Hansen KC; Ponik SM
    Sci Rep; 2018 Aug; 8(1):12941. PubMed ID: 30154546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
    Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
    Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP; Nicosia RF
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen reorganization at the tumor-stromal interface facilitates local invasion.
    Provenzano PP; Eliceiri KW; Campbell JM; Inman DR; White JG; Keely PJ
    BMC Med; 2006 Dec; 4(1):38. PubMed ID: 17190588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma.
    Walker RA; Dearing SJ; Gallacher B
    Br J Cancer; 1994 Jun; 69(6):1160-5. PubMed ID: 7515264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome.
    Reddy LA; Mikesh L; Moskulak C; Harvey J; Sherman N; Zigrino P; Mauch C; Fox JW
    J Proteome Res; 2014 Nov; 13(11):4739-51. PubMed ID: 25244421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWATH mass spectrometry as a tool for quantitative profiling of the matrisome.
    Krasny L; Bland P; Kogata N; Wai P; Howard BA; Natrajan RC; Huang PH
    J Proteomics; 2018 Oct; 189():11-22. PubMed ID: 29501709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
    Tökés AM; Hortoványi E; Csordás G; Kulka J; Mózes G; Hatalyák A; Kádár A
    Anticancer Res; 1999; 19(1A):175-9. PubMed ID: 10226540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Åhrman E; Hallgren O; Malmström L; Hedström U; Malmström A; Bjermer L; Zhou XH; Westergren-Thorsson G; Malmström J
    J Proteomics; 2018 Oct; 189():23-33. PubMed ID: 29501846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer.
    McCart Reed AE; Song S; Kutasovic JR; Reid LE; Valle JM; Vargas AC; Smart CE; Simpson PT
    Virchows Arch; 2013 Oct; 463(4):535-45. PubMed ID: 23942617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of thrombospondin and integrin alpha V in DCIS, invasive ductal and lobular human breast carcinomas. Analysis by electron microscopy.
    Serre CM; Clezardin P; Frappart L; Boivin G; Delmas PD
    Virchows Arch; 1995; 427(4):365-72. PubMed ID: 8548120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Odontogenic myxoma--characterisation of the extracellular matrix (ECM) of the tumour stroma.
    Schmidt-Westhausen A; Becker J; Schuppan D; Burkhardt A; Reichart PA
    Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):377-80. PubMed ID: 7536506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
    Yang Z; Ni W; Cui C; Fang L; Xuan Y
    Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic density is related to stroma and stromal proteoglycan expression.
    Alowami S; Troup S; Al-Haddad S; Kirkpatrick I; Watson PH
    Breast Cancer Res; 2003; 5(5):R129-35. PubMed ID: 12927043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extracellular matrix infrastructure provides support for murine secondary palatal shelf remodelling.
    Morris-Wiman J; Brinkley L
    Anat Rec; 1992 Dec; 234(4):575-86. PubMed ID: 1280922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
    Gould VE; Koukoulis GK; Virtanen I
    Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aligned collagen is a prognostic signature for survival in human breast carcinoma.
    Conklin MW; Eickhoff JC; Riching KM; Pehlke CA; Eliceiri KW; Provenzano PP; Friedl A; Keely PJ
    Am J Pathol; 2011 Mar; 178(3):1221-32. PubMed ID: 21356373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.
    Giussani M; Merlino G; Cappelletti V; Tagliabue E; Daidone MG
    Semin Cancer Biol; 2015 Dec; 35():3-10. PubMed ID: 26416466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.